Real-World Studies
Functional outcomes in oncology patients receiving chiropractic care: a retrospective chart review
Siegel et alSupportive Care in Cancer
Musculoskeletal disorders and associated pain represent frequent adverse effects of oncology treatments, including chemotherapy, radiation therapy, endocrine therapy, and surgery. These symptoms often restrict range of motion and impair activities of daily living. In a supportive oncology setting, conservative neuromuscular interventions—such as chiropractic care utilizing low-force spinal manipulative therapy and myofascial techniques—may address treatment-related musculoskeletal challenges.
A single-arm retrospective observational study assessed outcomes among 97 oncology patients managed at a regional comprehensive cancer hospital. Researchers examined changes in patient-specific function using the Patient-Specific Functional Scale (PSFS) alongside pain intensity ratings recorded across visits. Linear mixed-effects models demonstrated statistically significant improvements across the treatment timeline (p < 0.001). Functional scores on the PSFS increased from a baseline mean of 4.45 to 5.13 at the first follow-up (FU1) and 5.53 at the second follow-up (FU2). Concurrently, average pain intensity scores declined from 6.07 at baseline to 5.10 at FU1 and 4.64 at FU2.
While these retrospective findings demonstrate measurable gains in function and reductions in pain, the authors noted limitations, including the lack of a comparison control group and variability in specific chiropractic treatment modalities utilized. Prospective controlled trials are warranted to further clarify the role of chiropractic care within multimodal supportive oncology.
Key Takeaways
- Patient-Specific Functional Scale scores improved significantly from a baseline mean of 4.45 to 5.13 at the first follow-up and 5.53 at the second follow-up (p < 0.001).
- Mean pain intensity decreased significantly across visits from 6.07 at baseline to 5.10 at the first follow-up and 4.64 at the second follow-up (p < 0.001).
Read the original sourceSupportive Care in Cancer
